Medicare Enrolled
Dr. Tyson Cobb, M.D.
Interventional Cardiology · Orange, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cobb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cobb?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cobb
Dr. Tyson Cobb is an interventional cardiology specialist in Orange, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Cobb performed 1,765 Medicare services across 1,110 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cobb received a total of $8,197 from 42 pharmaceutical and/or device companies across 445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cobb is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ 1,765 Medicare services
$8,197 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,765
Medicare services
Bottom 40% in CA for interventional cardiology
1,110
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~88 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
549 | $102 | $278 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
369 | $12 | $32 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
172 | $43 | $121 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
62 | $173 | $449 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
60 | $102 | $244 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
48 | $47 | $124 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
48 | $22 | $64 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
48 | $208 | $528 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
46 | $76 | $222 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
44 | $60 | $157 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 42 | $417 | $1,050 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
35 | $149 | $370 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
34 | $48 | $128 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $143 | $361 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $67 | $197 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
22 | $409 | $1,062 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
22 | $20 | $49 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
21 | $1,738 | $4,400 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
21 | $11 | $29 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
18 | $21 | $52 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
17 | $125 | $310 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
13 | $6 | $16 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $90 | $242 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.9% high complexity
23.7% medium
67.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,197
Total received (2018-2024)
Avg $1,171/year across 7 years
Top 45% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
445
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,993 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$205 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$559
2023
$765
2022
$1,247
2021
$1,468
2020
$847
2019
$1,814
2018
$1,497
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ShockWave Medical, Inc
$191
Novartis Pharmaceuticals Corporation
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Amgen Inc.
$36
SCPHARMACEUTICALS INC.
$36
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$30
Janssen Pharmaceuticals, Inc
$28
E.R. Squibb & Sons, L.L.C.
$20
Lilly USA, LLC
$18
Novo Nordisk Inc
$18
Merck Sharp & Dohme LLC
$16
Kiniksa Pharmaceuticals International, plc
$15
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 58.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,036
SANOFI-AVENTIS U.S. LLC
$817
Amgen Inc.
$675
Boehringer Ingelheim Pharmaceuticals, Inc.
$634
Cardiovascular Systems Inc.
$564
PFIZER INC.
$551
Abbott Laboratories
$460
Janssen Pharmaceuticals, Inc
$422
ABIOMED
$415
Astellas Pharma US Inc
$227
Chiesi USA, Inc.
$207
AstraZeneca Pharmaceuticals LP
$205
NOVARTIS PHARMACEUTICALS CORPORATION
$203
ShockWave Medical, Inc
$191
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$170
Kowa Pharmaceuticals America, Inc.
$160
Kestra Medical Technology Services, Inc.
$142
BIOTRONIK INC.
$141
E.R. Squibb & Sons, L.L.C.
$135
PORTOLA PHARMACEUTICALS, INC.
$111
Medtronic, Inc.
$104
CHIESI USA, INC.
$74
Gilead Sciences, Inc.
$73
SCPHARMACEUTICALS INC.
$51
ATRICURE, INC.
$50
iRhythm Technologies, Inc.
$39
Allergan Inc.
$32
Cardinal Health 200, LLC
$31
Regeneron Healthcare Solutions, Inc.
$30
CVRx, Inc.
$28
Merck Sharp & Dohme LLC
$28
Bardy Diagnostics, Inc.
$27
Lundbeck LLC
$19
Lilly USA, LLC
$18
Novo Nordisk Inc
$18
Philips Electronics North America Corporation
$18
Ultragenyx Pharmaceutical Inc.
$17
Medtronic Vascular, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$16
Kiniksa Pharmaceuticals International, plc
$15
AtriCure, Inc.
$14
Amarin Pharma Inc.
$13
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ANDEXXA · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE ATRICLIP LAA EXCLUSION · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · CLEVIPREX · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · ELELYSO · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · FARXIGA · FUROSCIX · HeartMate 3 Left Ventricular Dev · HeartWare HVAD · Impella · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LINQ II · Lexiscan · LifeVest · Livalo · MOUNJARO · MULTAQ · Mitra Clip system · MitraClip System · NORTHERA · OPTIS · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · Repatha · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · VERQUVO · VYNDAQEL · Vascepa · WAINUA · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
66
Per 100K population
2.1
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cobb is a cardiac & electrophysiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cobb experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cobb performed 549 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cobb receive payments from pharmaceutical companies?
Yes. Dr. Cobb received a total of $8,197 from 42 companies across 445 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cobb's costs compare to other interventional cardiologists in Orange?
Dr. Cobb's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cobb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Orange
Browse interventional cardiologists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology